Lamictal (lamotrigine) Chewable Dispersible Tablets

Company
GlaxoSmithKline

Approval Status
Approved June 1999

Treatment for
Neurology

Possible similar drugs
Lamictal Chewable Dispersible Tablets

Areas
Neurology & Nervous System

The approval of these efficacy supplements provide for the use of Lamictal as conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing antiepileptic drug.

Lamictal Drug Information

The Lamictal drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top